Sector valuations Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
End-of-day quote
Wiener Boerse
21/08/2026
|
5-day change | 1st Jan Change | ||
| 59.60 EUR | -1.57% |
|
+2.14% | -5.85% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 35.55x | 22.67x | 0.68x | 12.84x | 26.06x | 27.6x | 0.55% | 1,10900Cr | ||
| 29.74x | - | -1.61x | - | - | - | 2.01% | 64TCr | ||
| 33.42x | -366.75x | 0.14x | 7.74x | 16.11x | 16.72x | 2.62% | 46TCr | ||
| 20.72x | 7.44x | 1.74x | 4.91x | 12.16x | 13.49x | 2.69% | 37TCr | ||
| 22.47x | 6.32x | -9.44x | 5.78x | 14.33x | 15.29x | 2.76% | 30TCr | ||
| 21.12x | 4.75x | 1.09x | 4.35x | 12.35x | 13.07x | 2.02% | 26TCr | ||
| 27.43x | 20.73x | 2.47x | 7.09x | 12.59x | 16.27x | 2.33% | 23TCr | ||
| 13.47x | 5.61x | -2.96x | 4.79x | 10.05x | 11.7x | 3.81% | 20TCr | ||
| -43.83x | 9.76x | 0.3x | 6.34x | 24.76x | 60.63x | 2.3% | 18TCr | ||
| 17.41x | 1.8x | 1x | 3.31x | 8.44x | 9.63x | 6.2% | 16TCr | ||
| 31.86x | 6.04x | 2.98x | 9.32x | 21.07x | 21.98x | -.--% | 14TCr | ||
| 11.66x | 5.5x | 0.19x | 3.26x | 8.46x | 9.17x | 3.86% | 13TCr | ||
| 12.36x | 1.26x | -7.3x | 2.2x | 7.1x | 7.9x | 5.47% | 11TCr | ||
| 14.52x | 4.67x | -2.32x | 2.83x | 8.38x | 9.33x | 3.62% | 10TCr | ||
| 23.04x | 5.2x | 1.37x | 7.76x | 14.72x | 15.45x | 1.92% | 7.36TCr | ||
| 47.52x | 1.25x | 100.29x | 2.82x | 9.94x | 29.64x | 3.51% | 5.86TCr | ||
| 20.79x | 1.7x | -0.13x | 1.7x | 8.04x | 13.57x | 0.32% | 5.58TCr | ||
| 36.35x | 5.01x | 2.36x | 8.32x | 28.26x | 29.71x | 0.55% | 4.85TCr | ||
| 49.38x | 4.95x | -1.29x | 3.3x | 12.16x | 13.76x | -.--% | 4.29TCr | ||
| Average | 22.37x | -14.01x | 4.71x | 5.48x | 14.17x | 18.61x | 2.45% | 24.65TCr | |
| Weighted average by Cap. | 24.85x | -31.55x | 0.74x | 7.53x | 17.03x | 20.19x | 2.15% |
Select your edition
All financial news and data tailored to specific country editions
















